ReviewPlant communications2026
Transcending the jasmonate-mediated growth-defense trade-off: Pathways to unlocking plant potential.
Review in Plant communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Jasmonate (JA) is a key phytohormone that balances defense and growth processes to orchestrate plant survival in response to external conditions. Although JA-mediated resistance to biotic and abiotic threats offers promising avenues for crop improvement, its concurrent growth suppression poses a fundamental challenge in agricultural practices. This review synthesizes recent advances in the understanding of the JA-mediated growth-defense trade-off (GDT), with a special focus on innovative strategies to decouple JA-induced defenses from growth inhibition, including expanding photosynthetic capacity, rewiring JA signaling, optimizing rapid JA bursts, and degrading targeted proteins via subtype-selective JA agonists. We propose future research directions for further transcending JA-mediated GDT in crops, such as fine-tuning chloroplast function, manipulating damage-associated molecular patterns signaling, and remodeling JA regulators. By integrating these insights, we provide a strategic framework for fundamentally re-engineering JA pathways to develop plants with greater resilience and sustained productivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.